WiSys Technologies

14 WiSys Technologies in "Agriculture" or "Pharmaceuticals & Vitamin D"

Quorum Quenching Functional Enzymes to Inhibit Bacterial Soft Rot

WiSys is seeking strategic partners interested in the commercial use of this innovation.

Incubator for Perch Larvae

WiSys is seeking strategic partners interested in the commercial use of this innovation

Adhesive Patch for Safe Application of Dehorning Paste with Calves

WiSys is currently seeking development partners for the optimization of the prototype and adhesive, as well as strategic partners for its manufacture who could provide a route to market for commercialization.

Immunogenic Composition to Prevent Francisella Infections in Fish

Researchers from the University of Wisconsin - Stevens Point are part of a multi-institution research team that has developed a vaccine with proven efficacy in preventing Francisella infections in fish.

Optimized Method for the Aqueous Extraction of Anthocyanins from Fruit Waste

WiSys is seeking a strategic partner interested in providing a route to market for the commercialization and use of this anthocyanin extraction system.  There is also interest in partnering with a fruit processing company for the continued testing and scaling of this system.

Wind Shield to Improve Overwinter Beehive Survival

WiSys is seeking a strategic commercial partner for development of this beehive wind shield for mass manufacturing, as well as partners for marketing, sales, and distribution.

Skin Whitening Agent(s)

WiSys Technology Foundation is currently seeking a strategic industry partner to assist in the further development of its lead compound, A11, and related analogues providing a route to market for their use as novel skin whitening/lightening agents.The competitive advantage of these compounds over existing agents on the market is that they produce long-acting and reversible skin lightening with no toxicity.

Benzodiazepine Derivatives with Reduced Side Effects

The WiSys Technology Foundation is seeking commercial partners interested in developing anxiolytic and anticonvulsant benzodiazepines that offer little or no side effects.